ACST — Acasti Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual balance sheet for Acasti Pharma, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	C2020 March 31st	2021 March 31st	C2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	14.2	60.7	43.7	27.9	23
Net Total Receivables	0.546	0.53	0.548	0.802	0.722
Prepaid Expenses
Total Other Current Assets
Total Current Assets	18.5	62.4	45.3	29.3	24
Gross Property, Plant And Equipment
Net Property, Plant And Equipment	0.147	0.086	0.565	0.567	0.024
Net Goodwill
Net Intangible Assets
Total Assets	22.9	62.5	129	79.1	73.3
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities	7.39	1.58	3.26	3.41	1.68
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	9.86	6.8	20.4	11.2	11.6
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	13	55.7	108	68	61.7
Total Liabilities & Shareholders' Equity	22.9	62.5	129	79.1	73.3
Total Common Shares Outstanding